{
    "ROS1 Rearrangement Positive": {
        "First-line Therapy": {
            "Crizotinib": "Progression (See NSCL-23)",
            "Entrectinib": "Progression (See NSCL-23)",
            "Ceritinib": "Progression (See NSCL-23)"
        },
        "Progression": {
            "Lorlatinib": "Progression (See NSCL-23)",
            "Chemotherapy": "Progression (See NSCL-23)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}